These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease. Xiao H; Zhang GF; Liao XP; Li XJ; Zhang J; Lin H; Chen Z; Zhang X Int J Rheum Dis; 2018 Feb; 21(2):477-486. PubMed ID: 29316328 [TBL] [Abstract][Full Text] [Related]
47. Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease. Ge J; Tang L; Mu P; Zhu F; Xie L; Tang Y Immunol Invest; 2020 Feb; 49(1-2):134-145. PubMed ID: 31469350 [TBL] [Abstract][Full Text] [Related]
49. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865 [TBL] [Abstract][Full Text] [Related]
50. Fragmented gelsolins are increased in rheumatoid arthritis-associated interstitial lung disease with usual interstitial pneumonia pattern. Suhara K; Miyazaki Y; Okamoto T; Ishizuka M; Tsuchiya K; Inase N Allergol Int; 2016 Jan; 65(1):88-95. PubMed ID: 26666486 [TBL] [Abstract][Full Text] [Related]
51. Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis. Jaeger VK; Lebrecht D; Nicholson AG; Wells A; Bhayani H; Gazdhar A; Tamm M; Venhoff N; Geiser T; Walker UA Sci Rep; 2019 Apr; 9(1):5500. PubMed ID: 30940853 [TBL] [Abstract][Full Text] [Related]
52. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort. Hoffmann-Vold AM; Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Lund MB; Aaløkken TM; Molberg Ø Am J Respir Crit Care Med; 2019 Nov; 200(10):1258-1266. PubMed ID: 31310156 [No Abstract] [Full Text] [Related]
53. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031 [TBL] [Abstract][Full Text] [Related]
54. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Adegunsoye A; Vij R; Noth I Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786 [TBL] [Abstract][Full Text] [Related]
55. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis. Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858 [TBL] [Abstract][Full Text] [Related]
56. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis. Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H Respir Med; 2019; 154():122-126. PubMed ID: 31238182 [TBL] [Abstract][Full Text] [Related]
57. Clubbing in patients with fibrotic interstitial lung diseases. van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102 [TBL] [Abstract][Full Text] [Related]